Comparison |
| Alternate Manufacturer Number |
| 3690799 | 3696549 | 2046720 | 1517812 |
| Alternate Packaging |
CT/10 | | CT/10 | CT/10 | |
| Container Type |
Prefilled Syringe | Single-Dose Vial | Single-Dose Vial | Single-Dose Vial | Multiple-Dose Vial |
| Country of Origin |
United States | Unknown | France | Unknown | India |
| Generic Drug Code |
17142 | 17150 | 17150 | 17142 | 17150 |
| Generic Drug Name |
Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl |
| NDC Number |
76329336901 | 17478004101 | 70069007110 | 76329146901 | 55150032810 |
| Strength |
1 mg / mL | 0.4 mg / mL | 0.4 mg / mL | 1 mg / mL | 0.4 mg / mL |
| Volume |
2 mL | 1 mL | 1 mL | 2 mL | 10 mL |
| Application |
Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Type |
Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous |
| UNSPSC Code |
51142315 | 51142315 | 51142315 | 51142315 | 51142315 |
| Features and Benefits |
- Generic Equivalent to Narcan®; Evzio™
- Luer-Jet™ needleless syringe
- Color-coded packaging - industry standard color-coding to aid in quick, reliable identification
- Emergency Syringes provided in completely needleless Luer Lock syringes, complies with OSHA's Needlestick Safety and Prevention Act and are compatible with most Luer Activated Systems (includes ICU Medical Clave® Valve)
|
|
- Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
- Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
- The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
- Store at 20° to 25°C (68° to 77°F)
- Protect from light by retaining in the carton until ready for use
- Single-dose glass flip top vial
- 10 vials per carton
|
|
|
